Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?

Reducing the recurrence rate in patients with low-risk non-muscle invasive bladder cancer patients is a critical concern in the urologic community. The gold standard treatment is single instillation (SI) of intravesical chemotherapy after transurethral resection of bladder tumor (TURBT), but unfortu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chemi, Joaquin, Villoldo, Gustavo Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bladder 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062473/
https://www.ncbi.nlm.nih.gov/pubmed/37006950
http://dx.doi.org/10.14440/bladder.2023.848
_version_ 1785017499657437184
author Chemi, Joaquin
Villoldo, Gustavo Martin
author_facet Chemi, Joaquin
Villoldo, Gustavo Martin
author_sort Chemi, Joaquin
collection PubMed
description Reducing the recurrence rate in patients with low-risk non-muscle invasive bladder cancer patients is a critical concern in the urologic community. The gold standard treatment is single instillation (SI) of intravesical chemotherapy after transurethral resection of bladder tumor (TURBT), but unfortunately, it is underused. Continuous bladder irrigation (CBI) after TURBT is an alternative strategy to SI for the prevention of bladder tumor implantation and recurrence. The aim of this review was to present the evidence that supports CBI after TURBT when SI is not possible.
format Online
Article
Text
id pubmed-10062473
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bladder
record_format MEDLINE/PubMed
spelling pubmed-100624732023-03-31 Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer? Chemi, Joaquin Villoldo, Gustavo Martin Bladder (San Franc) Review Reducing the recurrence rate in patients with low-risk non-muscle invasive bladder cancer patients is a critical concern in the urologic community. The gold standard treatment is single instillation (SI) of intravesical chemotherapy after transurethral resection of bladder tumor (TURBT), but unfortunately, it is underused. Continuous bladder irrigation (CBI) after TURBT is an alternative strategy to SI for the prevention of bladder tumor implantation and recurrence. The aim of this review was to present the evidence that supports CBI after TURBT when SI is not possible. Bladder 2023-03-17 /pmc/articles/PMC10062473/ /pubmed/37006950 http://dx.doi.org/10.14440/bladder.2023.848 Text en © 2013-2023 Bladder, All rights reserved. https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License: http://creativecommons.org/licenses/by-nc-sa/4.0
spellingShingle Review
Chemi, Joaquin
Villoldo, Gustavo Martin
Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
title Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
title_full Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
title_fullStr Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
title_full_unstemmed Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
title_short Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
title_sort should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062473/
https://www.ncbi.nlm.nih.gov/pubmed/37006950
http://dx.doi.org/10.14440/bladder.2023.848
work_keys_str_mv AT chemijoaquin shouldcontinuousbladderirrigationberecommendedwhensingleinstillationofintravesicalchemotherapycannotbeusedaftertransurethralresectioninlowrisknonmuscleinvasivebladdercancer
AT villoldogustavomartin shouldcontinuousbladderirrigationberecommendedwhensingleinstillationofintravesicalchemotherapycannotbeusedaftertransurethralresectioninlowrisknonmuscleinvasivebladdercancer

Ejemplares similares